HEALTH ECONOMICS BLOG - Trends, Politics, Opinions etc. in biotech & pharma industry

Folks an article on the intensified pricing collaboration activities among European countries. This has been a long debate for years but it seems more concrete steps are undertaken. Its a pity t...

http://www.healtheconomicsblog.com/2017/05/southern-eu-states-present-unified.html

Dear All, Olivier, the "work horse" ;) finally managed to get all the chapters back from the various authors and the book goes into print. Book should be available at Routledge in a couple o...

http://www.healtheconomicsblog.com/2016/10/the-future-of-health-economics-new-book_4.html

Hi All, just saw an interesting post (https://www.iqwig.de/en/press/press-releases/press-releases/adaptive-pathways-ema-still-leaves-open-questions-unanswered.7492.html ) from IQWIG, that speak...

http://www.healtheconomicsblog.com/2016/08/iqwig-not-bullish-on-emas-adaptive.html

Financial Times By Andrew Ward April 25, 2016   What is the value of a human life? It is one of the most fraught questions in public policy as governments around the world struggle with ...

http://www.healtheconomicsblog.com/2016/04/drug-prices-tweaking-formula.html

Dear Readers, I am currently building my access team in EMEA and have a few positions open. I am looking for a patient access lead oncology Switzerland/Austria. See job posting: https://lnkd.in/...

http://www.healtheconomicsblog.com/2015/11/patient-access-positions-with-baxalta.html

Dear All, Some interesting developments on the Cancer Drug Fund have been announced today. Cheers Ulf

http://www.healtheconomicsblog.com/2015/07/england-nhs-cancer-drug-fund-to-be.html

Dear All, hope you are getting ready for the summer.. just came across an interesting post on the GKV Spitzenverband website . A latest study from the Technical University of Berlin demonstrat...

http://www.healtheconomicsblog.com/2015/06/dear-all-hope-you-are-getting-ready-for.html

Dear All, first of all apologies for the quite time lately, been busy with various projects. Seeing the article from Ed it reminded me of the ever ongoing discussion about the value topic and...

http://www.healtheconomicsblog.com/2015/03/the-value-discussion.html

Dear All, just saw this on BBC Now if that scheme materializes it truly deserves to be called an innovative one .. Cheers Ulf

http://www.healtheconomicsblog.com/2014/10/potential-pay-if-you-are-clear-access.html

Dear All, a little post from the beach, I trust most of the readers enjoying their well deserved summer vacation. By popular demand in the past when I conducted and published my salary review, ...

http://www.healtheconomicsblog.com/2014/07/jobs-and-interviewing-in-market-access.html

Dear All, CatSalut has published a first version of guidelines for the implementation of payment by results schemes for pharmaceuticals. http://www20.gencat.cat/docs/salut/Minisite/catsalut/P...

http://www.healtheconomicsblog.com/2014/05/guidelines-for-payment-by-results-in.html

Dear all, pricing of cancer drugs and now also hepatitis C has steered another debate among US payers and physicians about drug prices. See a recent article in business week. Cheers Ulf

http://www.healtheconomicsblog.com/2014/05/no-linear-association-between-drug.html

Dear Readers, just saw this in the news (see link below). Germany is thinking of issuing a new law that the so far confidential price discounts be made public. That would be an entire new ballg...

http://www.healtheconomicsblog.com/2014/02/germany-becoming-wild-card-in-drug.html

Hi everyone, sitting here on my desk with a typical December cold, I came across this critique from the OHE of something that gives me even more headaches when reading it. I can't resist givin...

http://www.healtheconomicsblog.com/2013/12/critique-on-lower-nice-threshold.html

Dear All, it took some time for the UK government to come out with something on the VBP debate. Now the first details of the new "deal" emerged. What is now on the table looks quite different f...

http://www.healtheconomicsblog.com/2013/11/uk-vbp-paddling-back-big-time.html

Dear All, a new study has been presented at ESMO in Amsterdam. Researchers presented data on cancer spending in relation to overall mortality across the European Region. Not surprisingly confi...

http://www.healtheconomicsblog.com/2013/09/survival-and-spending-on-cancer-care-in.html

Hi All, today a post a little off our topic here but most important. Patti from healtheconomics.com posted this link , which I find very interesting. Its about flexibility in your daily working...

http://www.healtheconomicsblog.com/2013/06/no-hour-week.html

Dear All, VBP in the UK is around the corner and Hanson Wade (see post below) have invited Olivier and myself to run a pre-conference workshop on VBP. Looking forward to seeing many of you! B...

http://www.healtheconomicsblog.com/2013/05/vbp-event-september-24-26-london.html

Dear All, a recent paper in Blood sharply criticizes the pharmaceutical industry for the prices of cancer (CML) drugs. I am a little surprised that they have started to hinge the debate so muc...

http://www.healtheconomicsblog.com/2013/04/oncologists-critizise-cancer-drug.html

Dear All, now its out - NICE is broadening its role and will take on additional responsibilities as part of the VBP system in 2014. Some links on the matter: http://www.pharmafield.co.uk/Pf...

http://www.healtheconomicsblog.com/2013/03/nice-to-run-vbp-in-uk.html

Dear All, an interesting article from the Financial Times elaborating on the issues around VBP. It doesn't surprise me at all that they find it difficult to implement such a system. Indeed the...

http://www.healtheconomicsblog.com/2013/03/the-uk-nhs-struggles-to-implement-vbp.html

Dear All, in a recent newsletter BCN health  outlined that the Spanish Ministry is getting increasingly wary of too high prices on cancer drugs. They have stated that if the products fail to d...

http://www.healtheconomicsblog.com/2013/02/spanish-ministry-warns-of-excessive.html

Dear All, just got the word from eyeforpharma that the webinar on how to overcome the AMNOG hurdles to achieve access in Germany’s market was a great success last week. They’ve just finish...

http://www.healtheconomicsblog.com/2013/02/recordings-eyeforpharma-amnog-webinar.html

Dear All, this is a current search, please contact Theo (below) if interested. Cheers Ulf  As the Health Economics and Outcomes Research market continues to grow, this global consulta...

http://www.healtheconomicsblog.com/2013/02/heor-consultant-basle.html

...this I just saw on the BBC website, made me smile, especially the comment from Dr. Walker - he is definitely right in saying that it didn't need a big study to 'proof' that QALY's have many is...

http://www.healtheconomicsblog.com/2013/01/email-this-story.html